STREET’S EARNING ESTIMATES ON $AMGN (AMGEN) REMAIN TOO HIGH
We aggressively sold short $AMGN yesterday at $60.80 as per our plan in the earlier post. We take no issue with the positive trial results. Our issue is with the earning estimates of the street. Majority of $AMGN earnings come from anemia drugs. We continue to believe that these earnings